140 related articles for article (PubMed ID: 3876685)
21. Interaction of C1q and mannan-binding lectin (MBL) with C1r, C1s, MBL-associated serine proteases 1 and 2, and the MBL-associated protein MAp19.
Thiel S; Petersen SV; Vorup-Jensen T; Matsushita M; Fujita T; Stover CM; Schwaeble WJ; Jensenius JC
J Immunol; 2000 Jul; 165(2):878-87. PubMed ID: 10878362
[TBL] [Abstract][Full Text] [Related]
22. Antibody-independent interaction between the first component of human complement, C1, and the outer membrane of Escherichia coli D31 m4.
Aubert B; Chesne S; Arlaud GJ; Colomb MG
Biochem J; 1985 Dec; 232(2):513-9. PubMed ID: 3911948
[TBL] [Abstract][Full Text] [Related]
23. C1 activation, with C1q in excess of functional C1 in synovial fluid from patients with rheumatoid arthritis.
Sjöholm AG; Berglund K; Johnson U; Laurell AB; Sturfelt G
Int Arch Allergy Appl Immunol; 1986; 79(2):113-9. PubMed ID: 3484727
[TBL] [Abstract][Full Text] [Related]
24. The dissociation properties of native C1.
Ziccardi RJ; Tschopp J
Biochem Biophys Res Commun; 1982 Jul; 107(2):618-23. PubMed ID: 6289835
[No Abstract] [Full Text] [Related]
25. Serum levels of RHP and of unbound C1q in rheumatoid arthritis and systemic lupus erythematosus.
Rosano CL; Parhami N; Hechemy KE; Hurwitz C
Inflammation; 1988 Aug; 12(4):351-60. PubMed ID: 3262584
[TBL] [Abstract][Full Text] [Related]
26. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
[TBL] [Abstract][Full Text] [Related]
27. Secreted chondroitin sulfate proteoglycan of human B cell lines binds to the complement protein C1q and inhibits complex formation of C1.
Kirschfink M; Blase L; Engelmann S; Schwartz-Albiez R
J Immunol; 1997 Feb; 158(3):1324-31. PubMed ID: 9013976
[TBL] [Abstract][Full Text] [Related]
28. Physicochemical and functional characterization of the C1r subunit of the first complement component.
Ziccardi RJ; Cooper NR
J Immunol; 1976 Feb; 116(2):496-503. PubMed ID: 814163
[TBL] [Abstract][Full Text] [Related]
29. Prospective analysis of C1 dissociation and complement activation in patients with systemic lupus erythematosus.
Jonsson H; Sturfelt G; Mårtensson U; Truedsson L; Sjöholm AG
Clin Exp Rheumatol; 1995; 13(5):573-80. PubMed ID: 8575134
[TBL] [Abstract][Full Text] [Related]
30. Autoantibodies against Complement Classical Pathway Components C1q, C1r, C1s and C1-Inh in Patients with Lupus Nephritis.
Radanova M; Vasilev V; Mihaylova G; Kosturkova M; Kishore U; Roumenina L
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012546
[TBL] [Abstract][Full Text] [Related]
31. Antibody-independent activation of C1. I. Differences in the mechanism of C1 activation by nonimmune activators and by immune complexes: C1r-independent activation of C1s by cardiolipin vesicles.
Kovacsovics TJ; Peitsch MC; Kress A; Isliker H
J Immunol; 1987 Mar; 138(6):1864-70. PubMed ID: 3029222
[TBL] [Abstract][Full Text] [Related]
32. NH2-terminal calcium-binding domain of human complement C1s- mediates the interaction of C1r- with C1q.
Busby TF; Ingham KC
Biochemistry; 1990 May; 29(19):4613-8. PubMed ID: 2372546
[TBL] [Abstract][Full Text] [Related]
33. Surfactant protein A regulates complement activation.
Watford WT; Wright JR; Hester CG; Jiang H; Frank MM
J Immunol; 2001 Dec; 167(11):6593-600. PubMed ID: 11714829
[TBL] [Abstract][Full Text] [Related]
34. C1 subcomponent conplexes in normal and pathological sera studied by crossed immunoelectrophoresis.
Laurell AB; Mårtensson U; Sjöholm AG
Acta Pathol Microbiol Scand C; 1976 Dec; 84C(6):455-64. PubMed ID: 998270
[TBL] [Abstract][Full Text] [Related]
35. Recombinant human complement subcomponent C1s lacking beta-hydroxyasparagine, sialic acid, and one of its two carbohydrate chains still reassembles with C1q and C1r to form a functional C1 complex.
Luo C; Thielens NM; Gagnon J; Gal P; Sarvari M; Tseng Y; Tosi M; Zavodszky P; Arlaud GJ; Schumaker VN
Biochemistry; 1992 May; 31(17):4254-62. PubMed ID: 1533159
[TBL] [Abstract][Full Text] [Related]
36. Complement components, C1 activation and disease activity in SLE.
Sturfelt G; Sjöholm AG; Svensson B
Int Arch Allergy Appl Immunol; 1983; 70(1):12-8. PubMed ID: 6293980
[TBL] [Abstract][Full Text] [Related]
37. Mechanism of antibody-independent activation of the first component of complement (Cl) on retrovirus membranes.
Bartholomew RM; Esser AF
Biochemistry; 1980 Jun; 19(13):2847-53. PubMed ID: 6772208
[TBL] [Abstract][Full Text] [Related]
38. Activation of C1.
Colomb MG; Arlaud GJ; Villiers CL
Philos Trans R Soc Lond B Biol Sci; 1984 Sep; 306(1129):283-92. PubMed ID: 6149573
[TBL] [Abstract][Full Text] [Related]
39. High molecular weight non-immunoglobulin salivary agglutinins (NIA) bind C1Q globular heads and have the potential to activate the first complement component.
Boackle RJ; Connor MH; Vesely J
Mol Immunol; 1993 Feb; 30(3):309-19. PubMed ID: 8433709
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of C1q functions by RHP, a protein elevated in sera from patients with rheumatoid arthritis.
Rosano CL; Braun CB; Hechemy KE; Parhami N; Satoh PS; Hurwitz C
Complement; 1988; 5(2):57-64. PubMed ID: 3259913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
